Peter J. Smith

7.1k citations
147 papers · 5.3k · 1 hit paper · h-index 40

Impact in

  • Infectious Diseases top 0.5%
    • Tuberculosis Research and Epidemiology
    • HIV/AIDS drug development and treatment
  • Virology top 1%
    • HIV Research and Treatment

Papers in

  • Infectious Diseases 57
    • HIV/AIDS drug development and treatment 44
    • Tuberculosis Research and Epidemiology 17
  • Organic Chemistry 39
    • Free Radicals and Antioxidants 22
    • Radical Photochemical Reactions 17
Co-authors
Helen McIlleron (40 shared papers)Gary Maartens (20 shared papers)A. M. Monro (1 shared paper)Denise E. Robinson (1 shared paper)Gerald J. Kolaja (1 shared paper)Graham R. Betton (1 shared paper)Patrick D. Lilly (1 shared paper)William M. Bracken (1 shared paper)
Journals
Antimicrobial Agents and Chemotherapy (17 papers)Canadian Journal of Chemistry (11 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (6 papers)The Journal of Physical Chemistry (5 papers)European Journal of Clinical Pharmacology (4 papers)
Partner nations
South AfricaUnited StatesUnited Kingdom

In The Last Decade

Peter J. Smith

144 papers receiving 5.2k citations

Peter J. Smith's Hit Papers

Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals 2000 · 1.4k citations
1.4k0+8+17Years since publication4008001.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2000 Regulatory Toxicology and Pharmacology

Peers

Peter J. Smith
Comparison fields: 5 of 168
  • Infectious Diseases 2.0k
  • Virology 491
  • Pharmacology 899
  • Pharmacology 632
  • Small Animals 239
Replace Pieter Annaert with:
Pieter Annaert Belgium
Jürgen Burhenne Germany
Hilde Rosing Netherlands
Jiunn H. Lin United States
Chandra Prakash United States
Dennis A. Smith United Kingdom
William Trager United States
Stephen A. Ward United Kingdom
Laurent A. Décosterd Switzerland
James J. Keirns United States
Peter J. Smith relative to Pieter Annaert Belgium Pieter Annaert's profile →
Citations per field
00.5×2×2.6×
Pieter Annaert · 1×
Citations per year

Countries citing papers authored by Peter J. Smith

Since Specialization
Citations

This map shows the geographic impact of Peter J. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Smith more than expected).

Fields of papers citing papers by Peter J. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Smith. The network helps show where Peter J. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter J. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter J. Smith Line = papers co-authored together Peter J. Smith links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals
Regulatory Toxicology and Pharmacology ·Harry M. Olson, Graham R. Betton, Denise E. Robinson, Karluss Thomas, A. M. Monro, Gerald J. Kolaja, Patrick D. Lilly, James Sanders, Glenn Sipes, William M. Bracken, Michael A. Dorato, Koen Van Deun, Peter J. Smith, Bruce M. Berger, Allen H. Heller
Hit paper breakdown →		20001417
2
Early Bactericidal Activity of High-Dose Rifampin in Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum Smears
Antimicrobial Agents and Chemotherapy ·Andreas H. Diacon, R. F. Patientia, Amour Venter, Paul D. van Helden, Peter J. Smith, Helen McIlleron, J. S. Maritz, Peter R. Donald
2007152
3
Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption
Antimicrobial Agents and Chemotherapy ·Justin Wilkins, Radojka M. Savić, Mats O. Karlsson, Grant Langdon, Helen McIlleron, Goonaseelan Pillai, Peter J. Smith, Ulrika S. H. Simonsson
2008122
4
The SLCO1B1 rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications
Antimicrobial Agents and Chemotherapy ·Emmanuel Chigutsa, Marianne E Visser, Rina Swart, Paolo Denti, Sudeep Pushpakom, Deirdre Egan, Nicholas H. G. Holford, Peter J. Smith, Gary Maartens, Andrew Owen, Helen McIlleron
2011114
5
Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
Antimicrobial Agents and Chemotherapy ·Emmanuel Chigutsa, Jotam G. Pasipanodya, Marianne E. Visser, Paul D. van Helden, Peter J. Smith, Frederick A. Sirgel, Tawanda Gumbo, Helen McIlleron
2014105
6
Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery
Drug Discovery Today ·Moses M. Hohman, Kellan Gregory, Kelly Chibale, Peter J. Smith, Sean Ekins, Barry A. Bunin
2009100
7
Isoniazid Plasma Concentrations in a Cohort of South African Children with Tuberculosis: Implications for International Pediatric Dosing Guidelines
Clinical Infectious Diseases ·Helen McIlleron, Marianne Willemse, Cedric J. Werely, Gregory Hussey, H. Simon Schaaf, Peter J. Smith, Peter R. Donald
200992
8
Low Lopinavir Plasma or Hair Concentrations Explain Second-Line Protease Inhibitor Failures in a Resource-Limited Setting
JAIDS Journal of Acquired Immune Deficiency Syndromes ·Gert U. van Zyl, Thijs E. van Mens, Helen McIlleron, M. Zeier, Jean B. Nachega, Eric Decloedt, Carolina Malavazzi, Peter J. Smith, Yong Huang, Lize van der Merwe, Monica Gandhi, Gary Maartens
201192
9
Effect of Rifampicin on Lopinavir Pharmacokinetics in HIV-Infected Children With Tuberculosis
JAIDS Journal of Acquired Immune Deficiency Syndromes ·Yuan Ren, James Nuttall, Claire Egbers, Brian Eley, Tammy Meyers, Peter J. Smith, Gary Maartens, Helen McIlleron
200879
10
Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients
British Journal of Clinical Pharmacology ·Justin Wilkins, Grant Langdon, Helen McIlleron, Goonaseelan Pillai, Peter J. Smith, Ulrika S. H. Simonsson
201178
11
Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines
Antimicrobial Agents and Chemotherapy ·Helen McIlleron, Roxana Rustomjee, Mahnaz Vahedi, Thuli Mthiyane, Paolo Denti, Catherine Connolly, Wasima Rida, Alexander S. Pym, Peter J. Smith, Philip Onyebujoh
201273
12
A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients
Antimicrobial Agents and Chemotherapy ·Wynand Smythe, Akash Khandelwal, Corinne Merle, Roxana Rustomjee, M. Gninafon, Mame Bocar Lo, Oumou Bah Sow, Piero Olliaro, Christian Lienhardt, John Horton, Peter J. Smith, Helen McIlleron, Ulrika S. H. Simonsson
201273
13
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
European Journal of Clinical Pharmacology ·Catherine Orrell, Francesca Little, Peter J. Smith, Peter I. Folb, Walter R. J. Taylor, Piero Olliaro, Karen I. Barnes
200864
14
Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa.
PubMed ·Karen Cohen, Alison D. Grant, Collet Dandara, Helen McIlleron, Lindiwe Pemba, Katherine Fielding, Salome Charalombous, Gavin Churchyard, Peter J. Smith, Gary Maartens
200964
15
Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa
Antiviral Therapy ·Karen Cohen, Alison D. Grant, Collet Dandara, Helen McIlleron, Lindiwe Pemba, Katherine Fielding, Salome Charalombous, Gavin Churchyard, Peter J. Smith, Gary Maartens
200861
16
Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients
European Journal of Clinical Pharmacology ·Justin Wilkins, Grant Langdon, Helen McIlleron, Goonaseelan Pillai, Peter J. Smith, Ulrika S. H. Simonsson
200660
17
Pharmacogenetics of plasma efavirenz exposure in HIV‐infected adults and children in South Africa
British Journal of Clinical Pharmacology ·Phumla Sinxadi, Paul Leger, Helen McIlleron, Peter J. Smith, Joel A. Dave, Naomi Levitt, Gary Maartens, David W. Haas
201560
18
Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis
BMC Medicine ·H. Simon Schaaf, Marianne Willemse, Karien Cilliers, Demetre Labadarios, J.S. Maritz, Gregory Hussey, Helen McIlleron, Peter J. Smith, Peter R. Donald
200959
19
Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide
Tubercle and Lung Disease ·Clive S. Zent, Peter J. Smith
199558
20
High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients
Pharmacogenetics and Genomics ·Marelize Swart, Michelle Skelton, Yuan Ren, Peter J. Smith, Simbarashe Takuva, Collet Dandara
201358

About Peter J. Smith

Peter J. Smith is a scholar working on Infectious Diseases, Organic Chemistry, Physical and Theoretical Chemistry, Biophysics and Virology, having authored 147 papers that have together received 5.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (44 papers), Photochemistry and Electron Transfer Studies (23 papers), Free Radicals and Antioxidants (22 papers), Electron Spin Resonance Studies (20 papers), HIV Research and Treatment (18 papers), Tuberculosis Research and Epidemiology (17 papers), Radical Photochemical Reactions (17 papers) and Malaria Research and Control (17 papers). The work is most often cited by research in Infectious Diseases (2.0k citations), Virology (491 citations), Pharmacology (899 citations), Pharmacology (632 citations) and Small Animals (239 citations). Peter J. Smith has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Helen McIlleron, Gary Maartens, A. M. Monro, Denise E. Robinson, Gerald J. Kolaja, Graham R. Betton, Patrick D. Lilly, William M. Bracken, Karluss Thomas and Bruce M. Berger. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Canadian Journal of Chemistry, JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Physical Chemistry and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieter AnnaertBreakdown of academic impact, for papers by Jürgen BurhenneBreakdown of academic impact, for papers by Hilde RosingBreakdown of academic impact, for papers by Jiunn H. LinBreakdown of academic impact, for papers by Chandra PrakashBreakdown of academic impact, for papers by Dennis A. SmithBreakdown of academic impact, for papers by William TragerBreakdown of academic impact, for papers by Stephen A. WardBreakdown of academic impact, for papers by Laurent A. DécosterdBreakdown of academic impact, for papers by James J. Keirns